Product review · Updated September 30, 2026
Paula’s Choice UK Peptide Booster review: six peptides, two study summaries
The il418v2 declaration, unquantified peptide count and separate short-term and four-week evidence claims.
Editorial source review, with no clinician sign-off or firsthand treatment experience claimed.
Paula's Choice describes its Pro-Collagen Multi-Peptide Booster as a treatment with six pro-collagen peptides. Six tells the reader how the formula is presented, not that it contains 6% peptide or that each named ingredient is present at the same amount. Its official UK page also carries two distinct study summaries that should not be collapsed into one result.
This review concerns the retained UK il418v2 declaration captured September 30, 2026. No copper ingredient is named in that complete list, so the booster is an other-peptide comparator here. The analysis does not transfer the UK version to every market, evaluate a supplied package or independently verify the brand's clinical claims.
In this article
The UK version is part of the product identity
The official page names Pro-Collagen Multi-Peptide Booster, and its complete ingredient declaration ends with the identifier il418v2. Retaining that code makes the source more specific than a brand name or a generic peptide-booster label. The review follows this captured UK record rather than assuming all regional packages have the same formula. UK product declaration.
The manufacturer describes a lightweight gel texture in its comparison with the earlier booster. Serum is the editorial format grouping for this reviewed topical product; we did not assess its feel. The public-record comparison provides context for asking whether documents identify matching versions before their claims are placed on a shared numerical scale.
The six-peptide statement does not state six quantities
The page's opening describes six pro-collagen peptides. Its list includes named peptide-related entries such as Palmitoyl Tetrapeptide-72 Amide, Sh-Polypeptide-121 and Palmitoyl Tripeptide-5. No copper ingredient is named. These are identity and count observations; they do not reveal a numerical concentration for each entry. Product headline and complete list.
Counting entries cannot establish equal amounts, a total peptide mass fraction or a clinical advantage. The Le Mieux review is linked for a separate ingredient-count question. Its document supplies no quantities for Paula's Choice, and the two records should not be treated as equivalent formulas because both use peptide counts in their presentation.
The short-term summary has its own population
The first clinical-results statement describes visibly smoothing fine lines at a fifteen-minute assessment. Its footnote identifies a study with 34 subjects and characterizes the finding as a short-term effect to prime the complexion. We report the timepoint as a study detail, not an application schedule or expectation for a particular person. Short-term study summary.
The retained page does not provide the full report needed to inspect the comparator, assessment tool or analysis. A short-term appearance claim also cannot be rewritten as proof of lasting tissue change. The firmness-language guide offers background on why visible effects and biological explanations need different support even when a product's marketing discusses both.
The four-week claim is a separate summary
The over-time section says the booster visibly firms, plumps and reduces wrinkles, with a footnote naming 31 subjects after four weeks. That differs from the 34-subject short-term account. The two counts and timepoints remain separate; the retained text does not establish that they are one population followed through both assessments. Four-week result wording.
We cannot pool the participants or create a combined response percentage. Nor can we independently reproduce either result without the underlying methods and report. The study-endpoint guide addresses the connection between a reported outcome, its population and its measurement. Here the official summaries are useful specifics, but they remain summaries rather than complete independently evaluated trials.
Efficacious-level language leaves the amounts unstated
The FAQ says the blend uses clinically efficacious levels and warns about products with more peptides but lower levels. That is the manufacturer's comparative positioning. The selected passage does not disclose the numerical amount of each peptide, the standard underlying the comparison or a product-matched head-to-head report. Brand explanation.
An assurance about levels cannot supply the missing quantitative formula, and a count alone cannot test that assurance. The PTR serum review offers a separate topic about printed mixture percentages. Its figures are not evidence for Paula's Choice and do not permit a cross-product ranking. We retain the FAQ's claim without adopting its implied superiority as an independently established conclusion.
The original booster should not substitute for this version
Paula's Choice explicitly distinguishes the newer Pro-Collagen Multi-Peptide Booster from the original Peptide Booster. It attributes newer, more specialized peptides and better targeted benefits to the newer formula while noting a similar lightweight gel texture. Those are the brand's claims about a revision, not proof that old and new evidence is interchangeable. Version comparison.
The retained UK code therefore remains relevant when discussing ingredients and study summaries. We have not checked every legacy or non-UK package, and we do not fill gaps by importing a familiar older list. A matching title, formula identifier and complete report would be necessary to determine whether another source actually describes the same product reviewed here.
The strongest conclusion preserves all three distinctions
The reviewed record gives a six-peptide product description, a complete il418v2 declaration and two result summaries with different groups and timepoints. No copper is named in that list. The individual peptide quantities and complete study methods remain unavailable in the selected passages. Declaration and evidence summaries.
Those details support a useful product review without a reconstructed formula or an independently verified efficacy claim. Count, amount and endpoint each retain their own meaning. The open question is what a matching report and quantitative specification would establish for this exact UK version. This review makes no personal prediction, routine recommendation or judgment that the comparator's lack of named copper makes it inferior.
Sources behind this reading
- Paula’s Choice: Plump + Firm Pro-Collagen Multi-Peptide Booster — UK ↗UK il418v2 full list, gel serum identity and distinct short/long study summaries · Checked September 30, 2026